Publication:
Effects of treatment with haloperidol and clozapine on the plasma concentrations of thyroid hormones in rats

dc.contributor.coauthorSamadi, A.
dc.contributor.coauthorZiaee M.
dc.contributor.coauthorIşıkhan, S.Y.
dc.contributor.coauthorSamadi, M.
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorUlusu, Nuriye Nuray
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T12:19:41Z
dc.date.issued2020
dc.description.abstractObjectives: psychoactive drugs are group of compounds used to treat severe mental problems, including psychosis, as well as other conditions. This study assessed clinically relevant side effects of haloperidol and clozapine on the thyroid hormones. Methods: haloperidol (0.05 and 2 mg/kg) or clozapine (0.5 and 20 mg/kg) was intraperitoneally injected to male Wistar rats for 28 days. The control group received 2 ml of physiological saline. A chemiluminescent immunoassay was used to measure the plasma levels of thyroid hormones. Results: plasma concentrations of thyroxine (T4) in rats treated with high-dose (2 mg/kg) of haloperidol decreased significantly compared to the control group (p=0.001). However, both low (0.5 mg/kg) and high clozapine (20 mg/kg) doses did not have a significant effect on the plasma concentrations of T4 and triiodothyronine (T3) (p>0.05). Neither of the compound had a significant effect on T3 plasma concentration levels (p>0.05). Conclusions: haloperidol and clozapine act via different mechanisms and may have dissociable effects on thyroid hormones. Following treatment with haloperidol, significant changes in T4, but not in T3, serum levels were observed. Haloperidol and clozapine had different effects on the thyroid hormone levels. These results indicate that antipsychotic treatment can contribute to the thyroid dysfunction. Therefore, greater caution should be applied to the antipsychotics use. The thyroid function of the patients should be closely monitored, while using these drugs.
dc.description.fulltextYES
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue2
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipUrmia University of Medical Sciences
dc.description.versionPublisher version
dc.description.volume54
dc.identifier.doi10.2478/enr-2020-0009
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR02224
dc.identifier.issn1210-0668
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-85085393415
dc.identifier.urihttps://doi.org/10.2478/enr-2020-0009
dc.keywordsNtipsychotics
dc.keywordsChemiluminescent
dc.keywordsThyroxine
dc.keywordsTriiodothyronine
dc.language.isoeng
dc.publisherSciendo
dc.relation.grantnoNA
dc.relation.ispartofEndocrine Regulations
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/8868
dc.subjectMedicine
dc.subjectHyperthyroidism
dc.subjectMyxedema
dc.subjectLevothyroxine sodium
dc.titleEffects of treatment with haloperidol and clozapine on the plasma concentrations of thyroid hormones in rats
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorUlusu, Nuriye Nuray
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
8868.pdf
Size:
289.11 KB
Format:
Adobe Portable Document Format